Description
Identification of therapeutically relevant gene mutations for Cancer
ONCQUER CTC TESTING (1 TEST)
Identification of therapeutically relevant gene mutations for Cancer
TAT:
Specimen Type:
Genomics Single Test
Other Tests
- 263%
-
263%
MPL Mutation Detection
Exon 10
-
264%
OncQuer TM Scout LB 56 Gene Test
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
OncQuer TM Scout LB 56 Gene Test
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
-
264%
ONCQUER(TM) AML COMBO PANEL
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
ONCQUER(TM) AML COMBO PANEL
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
Reviews
There are no reviews yet.